ABSTRACT
domain within the cardiac progenitor population. In the absence of Hey2 function an 23 increase in myocardial cell number and SHF progenitors was observed. We found that 24
Hey2 limited proliferation of SHF-derived cardiomyocytes in a cell-autonomous 25 manner, prior to heart tube formation, and further restricted the developmental 26 window over which SHF progenitors were deployed to the heart. Taken together, our 27 data suggests a role for Hey2 in controlling the proliferative capacity and cardiac 28 contribution of late-differentiating cardiac progenitors. 29
INTRODUCTION 30
Cardiac development is regulated by the activity of concerted signaling, 31 transcriptional and morphogenetic events. Subtle perturbations in these processes, 32 either genetic or environmental, can lead to congenital heart defects (CHD), the most 33 common class of congenital anomalies. It is now evident that the vertebrate heart is 34 built from two populations of progenitor cells, termed the first heart field (FHF) and 35 second heart field (SHF), which contribute to the heart in two successive windows of 36 differentiation. Cells of the FHF differentiate in an initial wave of cardiogenesis, 37 resulting in formation of the linear heart tube. Over a well-defined developmental 38 window, multi-potent, late-differentiating progenitors of the SHF migrate into the 39 poles of the heart tube to extensively remodel and add structure to the heart (Cai et al., Previously described primers were used for quantification of β-actin (Tang et al., 166 2007); ltbp3 (Zhou et al. 2011 ); tbx1 (Zhang et al., 2006) and amhc (Jia, et 
Small molecule treatments 170
The FGF receptor inhibitor SU5402 (Tocris 3300) was used at a concentration of 171 10μM from 16.5 to 20 hours post-fertilization (hpf) or from 19 to 24 hpf. BMP and 172
Notch signaling inhibitors dorsomorphin (Tocris 3093) and DAPT (Tocris 2634/10), 173
respectively, were used at a concentration of 10μM and 50μM between 16.5 and 20 174 hpf. Retinoic Acid (Sigma R2625) was added at a concentration of 0.1μM to 175 dechorionated embryos at 5.3 hpf (50% epiboly) for 1 hour. All compounds were 176 diluted into 1% DMSO in embryo medium. Vehicle controls were treated with 1% 177 DMSO. Incubations were performed at 28°C. 178
179

Imaging 180
Bright-field images were taken using a Zeiss AXIO Zoom V16. RNA in situ 181 hybridization images were captured using a Leica M205FA microscope with the LAS 182 V6 software package. Immunofluorescence (IF) confocal images were taken with a 183 Nikon A1R laser scanning confocal microscope. 184
185
Immunofluorescence, DAF-2DA staining and cell counting 186
Whole-mount IF was carried out as previously described (Alexander et al., 1998) . 187
Primary antibodies used were: α-MYH6 supernatant 1:10 (DSHB, S46); α-MHC 188 
Photoconversion and cell addition analysis 198
Photoconversion on myl7:nlsKikGR embryos was carried out as previously described 199 (Lazic and Scott, 2011) using the UV channel on a Zeiss Axio zoom V16 microscope. 200
Images were captured using a Nikon A1R laser scanning confocal. For mounting, 201 embryos were fixed in 4% PFA for 20 minutes and washed three times in PBS. 202
Embryos were agitated in 5% saponin/PBS 0.5%Tx-100 followed by dehydration to 203 75% glycerol/PBS and left overnight at 4°C. Hearts were dissected and flat mounted 204 prior to imaging. 205
206
EdU incorporation 207
EdU incorporation assays were performed as previously described (Zeng and Yelon, 208 2014 
Statistical analysis 216
Excel software was used to perform student t-tests with two-tail distribution. Graphs 217 display mean±s.e.m unless otherwise stated. Box plot graphs were prepared using 218 To further examine the role of Hey2 in cardiac development, we first carried out a 225 detailed analysis of hey2 expression during key stages of cardiogenesis, spanning 226 early cardiac specification to the formation of the linear heart tube, using whole-227 mount RNA in situ hybridization. Interestingly, hey2 transcripts were found to 228 localize anteromedial to those of nkx2.5 and mef2cb in the anterior lateral plate 229 mesoderm (ALPM) at 16.5 hours post-fertilization (hpf, Fig. 1A and D, respectively) . 230
At 20 hpf, when the primitive heart is organized into a cone of differentiating cardiac 231 cells (Yelon et al., 1999) , hey2 expression was again evident anteromedial to that of 232 myl7 and mef2cb (Fig. 1B and E) . We further observed a domain of hey2 expression 233 lateral to the heart cone, in the region of the pharyngeal mesoderm ( Fig. 1B and E,  234 white arrowheads). Following formation of the linear heart tube at 24 hpf, hey2 235 transcripts were detectable both within and extending from the distal portion of the 236 ventricle, a region occupied by mef2cb-positive cells of the presumptive SHF (Fig. 1C  237 and F; (Lazic and Scott, 2011 ). These results, as summarized in Figure 1G , suggest 238 that hey2 is an early marker of the late-differentiating progenitor population, as it is 239 expressed in a manner consistent with regions shown to contain SHF progenitors 240 expression was also observed immediately anterior to the heart cone, with these cells 259 having no detectable Tg(nkx2.5ZsYellow) expression ( Fig. K'' ; arrowhead), matching 260 the position of recently described isl2b-positive SHF cells (Witzel et al., 2017 Fig. 1B-F) . 268
269
To conclusively follow endogenous hey2 expression, we further used CRISPR/Cas9 270 genome editing to place an internal V5 epitope tag into the hey2 locus (supplemental 271 Fig. 1G ; Burg et al, 2016) . Tg(hey2-V5) hsc27 embryos were viable, demonstrating that 272 this allele was functional. Antibody staining versus V5 at 30 hpf showed V5-Hey2 273 localization to the posterior ventricular region of the heart tube ( Fig. 1M ; arrowhead 274 ventricle; arrow atrium), with a portion of CMs expressing both myl7:mCherry and 275 V5 ( Fig. 1M; asterisk) . This expression data replicates both endogenous expression of 276 hey2 (Fig. 1C) as well as enhancer expression of hey2 ( inhibitor, SU5402, we noted the expected reduction in ventricular cardiomyocyte 298 differentiation but normal atrial differentiation, as shown by vmhc and amhc 299 expression (supplemental Fig. 2A and B) . SU5402 treatment between 16.5 hpf and 20 300 hpf further resulted in reduced cardiac hey2 expression within the heart cone ( Fig. 2A  301 and B), with a coincident loss of detectable expression of the SHF progenitor marker 302 mef2cb (supplemental and recent controversy regarding use of antisense morpholinos to assess gene function 341 in zebrafish (Kok et al., 2015) in mind, we generated a novel predicted null mutation 342 in hey2 using CRISPR/Cas9-mediated genome editing. By targeting the hey2 343 transcript within exon2, we generated a mutant with an 8bp deletion producing a 344 premature stop codon at amino acid 53, effectively deleting the bHLH domain (Fig.  345   3A) . Both hey2 hsc25 mutant and morphant phenotypes become apparent by 48 hpf with 346 mutant embryos displaying a non-looped heart with a reduction in heart rate when 347 compared to controls (supplemental Fig. 3A-D) . At 72 hpf, hey2 mutant embryos 348 
Loss of Hey2 affects cardiac function and maturation 358
Given the irregular morphology of hey2 mutant hearts, we next investigated 359 cardiomyocyte-intrinsic defects. The function of the heart is highly dependent on 360 cardiomyocyte morphology, specifically cell shape (Auman et al., 2007) . 361
Cardiomyocytes initially have a uniform cuboidal characteristic that is altered as 362 ventricular chamber formation proceeds by both blood flow and cardiac contractility 363 (Manasek, 1981; Manasek et al., 1972; Taber, 2006) . To examine potential defects in 364 cardiac maturation, the hey2 hsc25 ,allele was crossed into a Tg(myl7:nlsDsRedExpress) 365 background. IF staining using antibodies against DsRed and zn-8 was used to 366 visualize cardiomyocyte cell nuclei and cell membranes, respectively. As compared to 367 sibling controls, in hey2 hsc25 mutants cardiomyocytes failed to initiate cellular 368 elongation near the atrio-ventricular canal (AVC) (Fig. 3H and I, arrowheads) . 369
Instead, cell shape remained uniform throughout the ventricle. This was quantified 370 through axis ratio measurements, which showed a significant difference in cell shape 371 at the AV boundary in hey2 hsc25 mutants compared to control embryos ( 
Expanded cardiomyocyte number in hey2 mutants 382
Based on the expression of hey2 prior to 24 hpf, we next analyzed the structure of the 383 heart tube between wild type and hey2 MO injected embryos. At 26 hpf, hey2 384 morphants had an irregularly shaped heart that had failed to elongate (Fig. 4A-D) , 385
with an expansion in expression of terminal differentiation markers myl7 and tnnt2 at 386 the poles of the heart (Fig. 4B and D, arrowheads) . Given this observation, we 387 counted CM number in wild type and hey2 morphant Tg(myl7nls:DsRedExpress) 388 embryos. Whereas control embryos contained 136.8±6 (mean±s.e.m, n=5) CMs at 24 389 hpf, hey2 morphant embryos contained a significantly greater number (170±3.6, 390
mean±s.e.m, n=5; Fig. 4E-G Fig. 4F-H) . These results highlight that in the absence of 396 hey2, an elevated addition of CMs to the heart is detectable as early as 24 hpf. 397
398
Increased proliferation of cardiac progenitors contributes to increased heart size 399 in the absence of hey2 function 400
Given the increased CM number observed in hey2 deficient embryos from as early as 401 24 hpf, we explored the hypothesis that this may be due to accelerated addition of 402 cardiac progenitors to the heart. Using whole-mount in situ hybridization and 403
quantitative RT-PCR, we observed a significant increase in the expression of nkx2.5, 404 mef2cb, ltbp3 and hey2 in hey2 morphants compared to WT controls within the 24 hpf 405 linear heart tube ( Fig. 5A-J) . At 48 hpf, we observed through IF staining a higher 406 number of Mef2-positive cells at the arterial pole of the two-chambered heart 407 (supplemental Fig. 4C-F) . As we noted that the effect of hey2 loss-of-function on CM 408 number is evident as early as 24 hpf, we next analyzed embryos at 16.5 hpf for gene 409 expression changes within the ALPM. Interestingly, we observed increased 410 expression of nkx2.5 (Fig. 5K, N and R) as well as broader expansion of mef2cb (Fig.  411 5L, O and Q) and hey2 ( (Fig. 1K'', asterisk) , we examined tbx1 expression in hey2 morphant 432 embryos and found an increase in tbx1 transcript levels at 16.5 hpf (Fig. 5T, U indicating that an increase in proliferation prior to heart tube formation contributes to 446 enhanced CM production (Fig. 5Y-Y'' ). In contrast, pulsing with EdU at 24 hpf 447 demonstrated no significant impact of hey2 loss on proliferation in CMs between 24-448 35 hpf (supplemental Fig. 4G-I) . Altogether, these results suggest an early role for 449
Hey2 in establishing the appropriate number of late-differentiating progenitors that 450 will be added to the heart prior to heart tube formation. 451
452
Myocardial accretion is extended in hey2 loss-of-function embryos 453
Previous work has demonstrated and quantified the differentiation and addition of 454 subsequent novel myocardial addition to the heart. We observed a substantial increase 459 in the number of differentiated CMs being added to the arterial pole in hey2 460 morphants (95±7.0) compared to WT controls (23.4±1.6), as shown by green only 461 cells at the arterial pole of the 48 hpf heart (Fig. 6A-D, brackets; mean±s.e.m, n=5) . 462
The normal timing of termination for myocardial addition has been reported to be 463 between 36 and 48 hpf (Jahangiri et OFT than that of sibling controls (Fig. 6I-K) . Together this demonstrates that in the 483 absence of Hey2, late-differentiating progenitors are subjected to an extended window 484 of accretion following an increase in proliferative activity, which ultimately leads to 485 an expansion in SHF-derived structures. 486 487 hey2 acts cell autonomously to regulate SHF addition to the heart at the expense 488
of the FHF population 489
We next employed a transplantation approach to examine the cell autonomy of Hey2 490 activity in cardiac progenitors. To accomplish this, Tg(myl7:nlsKikGR) donor 491 embryos, either WT or injected with hey2 MO, were used. Donor cells at 4 hpf (50% 492 epiboly) were transplanted to the margin of WT host embryos (Fig. 7A) , an approach 493 that has been shown to result in cardiac contribution of donor cells (Scott et al., 2007; 494 Stainier et al., 1993) . Transplant embryos were photoconverted at either 24 or 48 hpf 495 and imaged at either 48 or 60 hpf (Fig. 7B and F, respectively) . From our results we 496 observed that Hey2 morphant donor Tg(myl7:nlsKikGR) cells displayed a significant 497 increase in SHF contribution (shown by the ratio of green:yellow cardiomyocytes per 498 embryo), as compared to early myocardial addition, between 24 to 48 hpf (Fig. 7C-E) . 499
The same result was observed between 48 to 60 hpf, with Hey2 deficient 500 myl7:nlsKikGR donors contributing significantly more green only cardiomyocytes 501 than controls (Fig. 7F-I ). While the ratio in numbers of late versus early differentiated 502 cardiomyocytes per heart from hey2 donor cells was consistently increased at both 24-503 48 and 48-60 hpf, an analysis of cell numbers for each category revealed a bias in 504 progenitor populations. From 24-48 hpf, the increased late versus early CM addition 505 ratio observed in hey2 morphants was due to a decreased propensity for donor cells to 506 contribute early to the heart, evident by a significant decrease in total cell number of 507 yellow CMs in controls compared to morphant embryos (Fig. 7J) . However, when 508 comparing total number of late differentiating CMs, no statistical significance was 509 observed (Fig. 7J) . In contrast, the higher late versus early addition ratio observed at 510 48 hpf was due to a significantly higher amount of late (post 48 hpf) CM addition, 511 with a relatively equivalent amount of early (pre 48 hpf) CM addition as noted by no 512 significant change in early CM number between control and hey2 morphant embryos 513 (Fig. 7K ). These results demonstrate a cell-autonomous function for Hey2, in 514 presumptive cardiac progenitors, that delays their addition to the heart as 515 cardiomyocytes. 516
517
DISCUSSION 518
Our work demonstrates a novel role for the bHLH factor Hey2 in regulating the size 519 of the cardiac progenitor pool and the timing of the contribution of late-differentiating 520 cardiac progenitors to the zebrafish heart. As shown by fate mapping (Camp et 
Previous reports have highlighted that the cardiac malformations found in animals 546
lacking Hey2 function resemble common human congenital heart defects including 547 ventricular septal defects, tetralogy of fallot and tricuspid atresia (Donovan et al., 548 2002) . Coupled with the expression of hey2 during cardiac development, the effects 549 of hey2 loss on late myocardial addition to the zebrafish heart suggest a mechanism 550 where Hey2 acts specifically in SHF progenitors. While we did not observe 551 appreciable effects on FHF-associated markers in our study, this data is difficult to 552 interpret, as bona fide FHF-and SHF-specific markers that distinguish these 553 populations are poorly characterized. Our transplant assays strongly suggest that 554 cardiac contribution is at the very least delayed with the loss of hey2. The observed 555 phenotypes may reflect: 1) a shift in the balance between FHF and SHF progenitor 556 proliferation, favouring the SHF pool; 2) alteration in the timing of cardiac progenitor 557 differentiation; 3) changes in the number of progenitors allocated to the FHF and SHF 558 pools; or 4) a FHF/SHF-agnostic role for Hey2 in cardiac progenitor proliferation and 559 differentiation. This is a critical question that will require further study, but that may 560 provide insight into the diversity of early cardiac progenitors. 561
562
It is important to note that the function of hey2 in zebrafish cardiogenesis has been 563 previously addressed in an elegant study (Jia et al., 2007) . However, while the overall 564 "large heart" phenotype observed is shared between our hey2 hsc25 and the grl m145 565 mutants, our data suggests a role for hey2 prior to 24 hpf, in cardiac progenitors, that 566 subsequently impacts cardiac development. In contrast, Jia and colleagues reported 567 that grl had minimal affect during this time, with grl m145 mutants having comparable 568 cardiomyocyte numbers to controls at 24 hpf. This discrepancy may reflect the nature 569 of the hey2 alleles used, with the hey2 hsc25 allele being, we believe, a true null. As the 570 SHF and late myocardial addition in zebrafish had not been described at the time of 571 the prior study, this would have also affected the interpretation of the results. This 572 highlights the fact that Hey2 likely acts at multiple steps of heart development. 573
574
The myocardium of the AVC is important for the development of the AV cushion and 575 AV node, both derivatives of the SHF (Kelly, 2012) . In zebrafish, bmp4 and tbx2b are 576 expressed in the AV myocardium, and play critical roles in the establishment of AVC 577 identity (Ma et al., 2005; Zhang and Bradley, 1996 ). Here we demonstrate the 578 importance of Hey2 in AVC development. Although previous work revealed that the 579 grl m145 mutant shows an ectopic expansion of bmp4 expression at 48hpf, little change 580 was observed in tbx2b transcripts (Rutenberg et al., 2006) . However our mutant 581 hey2 hsc25 allele revealed upregulation in both bmp4 and tbx2b, thus providing insight 582 into a potential regulatory network by which hey2 expression in ventricular 583 myocardium constrains bmp4 expression to the AVC, which in turn activates tbx2b 584 expression (supplemental Fig. 4L ). In the absence of functional Hey2, this repression 585 is absent, resulting AVC-specific genes expanding their expression domains into the 586 cardiac chambers (supplemental Fig. 4M) . progenitors. To address these questions, lineage tracing approaches will be required, 596
for which the novel hey2 enhancer transgenics we have uncovered will be of great 597 utility. Given the cell autonomous function of Hey2, identifying its transcriptional 598 targets will also be of great interest. Given the role of Hey2 in restraining cardiac 599 progenitor proliferation, its down-regulation by RA, and the known role of epicardial 600 RA signaling in zebrafish heart regeneration (Kikuchi et al., 2011), a potential role for 601
Hey2 in regeneration should also be investigated. Dissecting how Hey2 regulates 602 cardiac development will help address key unanswered questions with respect to the 603 regulatory mechanisms that coordinate the size and differentiation timing of cardiac 604 progenitors to allow for proper heart development to proceed. 605
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